Quote:

---

The Company will accelerate manufacturing of leronlimab at Samsung BioLogics upon such approval.

---

This is the "cryptic" important thing in the presser.

We had around 1.2M vials available, if my recollection is correct.

So ... why accelerate manufacturing if we have enough to supply up to 200K vials ???

Also, the feeling was that 1/2 of in-hand vials would go to Brazil ...

Either BOD is very optimistic or there is the consensus that more will be needed.

Good news regardless ... this means revenue is coming our way.